The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Abstract
Alzheimer's disease (AD) is the most common cause of progressive intellectual failure in aged humans. AD brains contain numerous amyloid plaques surrounded by dystrophic neurites, and show profound synaptic loss, neurofibrillary tangle formation and gliosis. The amyloid plaques are composed of amyloid beta-peptide (A beta), a 40-42-amino-acid fragment of the beta-amyloid precursor protein (APP). A primary pathogenic role for APP/A beta is suggested by missense mutations in APP that are tightly linked to autosomal dominant forms of AD. A major obstacle to elucidating and treating AD has been the lack of an animal model. Animals transgenic for APP have previously failed to show extensive AD-type neuropathology, but we now report the production of transgenic mice that express high levels of human mutant APP (with valine at residue 717 substituted by phenylalanine) and which progressively develop many of the pathological hallmarks of AD, including numerous extracellular thioflavin S-positive A beta deposits, neuritic plaques, synaptic loss, astrocytosis and microgliosis. These mice support a primary role for APP/A beta in the genesis of AD and could provide a preclinical model for testing therapeutic drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mouse models that overexpress amyloid precursor protein (APP) develop plaques remarkably similar to those observed in AD but do not recapitulate neurofibrillary pathology or widespread neuronal loss (Games et al., 1995;Hsiao et al., 1996;Irizarry et al., 1997a;Urbanc et al., 2002), allowing interpretation of results in the context of amyloid-related pathologies.”
From Dendritic Spine Abnormalities in Amyloid Precursor Protein Transgenic Mice Demonstrated by Gene Transfer and Intravital Multiphoton Microscopy (2005) · cites this paper as Games et al., 1995
In the citing paper
“Similar to AD, APP transgenic mouse models have elevated inflammation markers and gliosis associated with amyloid deposits (Games et al., 1995; Hsiao et al., 1996; Sturchler-Pierrat et al., 1997).”
From Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation (2006) · cites this paper as Games et al., 1995
In the citing paper
“The first successful mouse models reproducing Aβ pathologies overexpressed human APP with either a single Swedish [25, 26] or Indiana [27] mutation.”
From Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer’s disease (2019) · cites this paper as [27]
In the citing paper
“The hAPP tg line J9 selected for this study expresses an alternatively spliced minigene, hA PP, bearing the amyloidogenic V717F and K670M / N671L mutations that have been linked to familial AD (Games et al., 1995).”
From Increased Extracellular Amyloid Deposition and Neurodegeneration in Human Amyloid Precursor Protein Transgenic Mice Deficient in Receptor-Associated Protein (2002) · cites this paper as Games et al., 1995
In the citing paper
“The J9 model utilizes a mini-APP gene that can produce all three isoforms of APP: APP695, APP751 and APP770 [41].”
From Receptor-Associated Protein (RAP) Plays a Central Role in Modulating Aβ Deposition in APP/PS1 Transgenic Mice (2008) · cites this paper as [41]
In the citing paper
“These genetic findings led to several transgenic mouse models that successfully recapitulated Aβ plaque formation, increasing support for the hypothesis (Table 1) [23–29].”
From Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau (2021) · cites this paper as [25]
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Manipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
Manipulating the mouse embryo: A laboratory manual
Johnson, M. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90275-1 · Cited by 2,259
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Self-citationQuantitation of mRNA by the polymerase chain reaction.
Wang, A. M., DOYLE, M. V., & Mark, D. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9717 · Cited by 1,630
Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., & Younkin, S. G. (1994) · Science · doi:10.1126/science.8191290 · Cited by 1,471
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J. R., Farlow, M. R., Ghetti, B. F., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,142
Normal and Abnormal Biology of the Beta-Amyloid Precursor Protein
Selkoe, D. J. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.002421 · Cited by 834
Roher, A. E., Lowenson, J. D., Clarke, S., Wolkow, C., Wang, R., Cotter, R. J., Reardon, I. M., Zürcher-Neely, H. A., Heinrikson, R. L., & Ball, M. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53661-9 · Cited by 799
Sasahara, M., Fries, J. W. U., Raines, E. W., Gown, A. M., Westrum, L. E., Frosch, M. P., Bonthron, D. T., Ross, R., & Collins, T. (1991) · Cell · doi:10.1016/0092-8674(91)90223-l · Cited by 411
Flagged first, then by citations
Research works printed but not linked: 4
- Mann, D. M. A. et al. Neurodegeneration 1, 201–215 (1992).
- McConlogue, L. et al. Neurobiol. Aging 15, S12 (1994).
- Masliah, E. et al. Am. J. Path. 138, 235–246 (1991).
- Chomazynski, P. & Sacchi, N. Analyt. Biochem. 162, 156–159 (1987).
Cited by
Sorted by citations
Items 801–900 of 1,029
Puig, B., Gómez‐Isla, T., Ribé, E. M., Cuadrado‐Tejedor, M., Torrejón-Escribano, B., Dalfó, E., & Ferrer, I. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00569.x · Cited by 88
Bronfman, F. C., Moechars, D., & LEUVEN, F. V. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0283 · Cited by 86
Transgenic mouse models of Alzheimer's disease
Hock, B. J., & Lamb, B. T. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02449-0 · Cited by 85
Kampers, T., Pangalos, M. N., Geerts, H., Wiech, H., & Mandelkow, E. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00522-0 · Cited by 86
Lehman, E. J. H. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg322 · Cited by 85
Modes of Aβ toxicity in Alzheimer’s disease
Götz, J., Eckert, A., Matamales, M., Ittner, L. M., & Liu, X. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0750-2 · Cited by 87
A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model
..., B., Shamasundar, N. M., Rao, T. S., Naidu, M. D., Ravid, R., & Rao, K. S. J. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.04.003 · Cited by 86
Role of Synucleins in Alzheimer’s Disease
Crews, L. A., Tsigelny, I. F., Hashimoto, M., & Masliah, E. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9073-6 · Cited by 85
Self-citationAlzheimers Disease: Interactions Between Cholinergic Functions and β- amyloid
Yan, Z., & Feng, J. (2004) · Current Alzheimer Research · doi:10.2174/1567205043331992 · Cited by 84
Best, J. D., Smith, D. W., Reilly, M., O’Donnell, R., Lewis, H. D., Ellis, S., Wilkie, N., Rosahl, T. W., Laroque, P. A., Boussiquet-Leroux, C., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.114330 · Cited by 84
Rivera, D. S., Lindsay, C. B., Codocedo, J. F., Morel-Letelier, I., Pinto, C., Cisternas, P., Bozinovic, F., & Inestrosa, N. C. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.06.021 · Cited by 84
Sani, S., Traul, D., Klink, A., Niaraki, N., Gonzalo-Ruiz, A., Wu, C.-K., & Geula, C. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0626-5 · Cited by 83
Rockenstein, E. M., Adame, A., Mante, M., Moessler, H., Windisch, M., & Masliah, E. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0025-7 · Cited by 83
Self-citationBrody, A. H., & Strittmatter, S. M. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.09.007 · Cited by 89
γ-Secretase Catalyzes Sequential Cleavages of the AβPP Transmembrane Domain
Xu, X. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0957 · Cited by 84
Imaging of cerebrovascular pathology in animal models of Alzheimer's disease
Klohs, J., Rudin, M., Shimshek, D. R., & Beckmann, N. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00032 · Cited by 82
Protein Kinase C ϵ Suppresses Aβ Production and Promotes Activation of α-Secretase
Zhu, G., Wang, D., Lin, Y., McMahon, T., Koo, E. H., & Messing, R. O. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5273 · Cited by 82
Hölscher, C. (2005) · Reviews in the Neurosciences · doi:10.1515/revneuro.2005.16.3.181 · Cited by 83
Fujiwara, N., Shimizu, J., Takai, K., Arimitsu, N. N., Saito, A., Kono, T., Umehara, T., Ueda, Y., Wakisaka, S., Tomoko, S., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.10.043 · Cited by 84
Savonenko, A. V., Xu, G. M., Price, D. L., Borchelt, D. R., & Markowska, A. L. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(02)00012-8 · Cited by 63
Sheng, J. G., Mrak, R. E., Bales, K. R., Cordell, B., Paul, S. M., Jones, R. A., Woodward, S., Zhou, X. Q., McGinness, J. M., & Griffin, W. S. T. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740295.x · Cited by 82
Complement in Alzheimer's disease: opportunities for modulating protective and pathogenic events
Tenner, A. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00301-3 · Cited by 81
The role of APOE in transgenic mouse models of AD
Balu, D., Karstens, A. J., Loukenas, E., Maldonado Weng, J., York, J. M., Valencia-Olvera, A. C., & LaDu, M. J. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134285 · Cited by 81
Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age
Abdul, H. M., Rukhsana Sultana, A., Clair, D. K. S., Markesbery, W. R., & Butterfield, D. A. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.08.012 · Cited by 81
High mobility group box protein‐1 inhibits microglial Aβ clearance and enhances Aβ neurotoxicity
Takata, K., Kitamura, Y., Tsuchiya, D., Kawasaki, T., Taniguchi, T., & Shimohama, S. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20340 · Cited by 82
Diez, M., Koıstınaho, J., Kahn, K., Games, D., & Hökfelt, T. G. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00261-x · Cited by 81
Self-citationThe Relationship between Amyloid and Tau
Hardy, J. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:2:203 · Cited by 80
Lam, V., Takechi, R., Hackett, M. J., Francis, R., Bynevelt, M., Celliers, L. M., Nesbit, M., Mamsa, S., Arfuso, F., Das, S., et al. (2021) · PLOS Biology · doi:10.1371/journal.pbio.3001358 · Cited by 80
Alzheimer's Disease and Amyloid: Culprit or Coincidence?
Skaper, S. D. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00011-9 · Cited by 82
Murine models of Alzheimer's disease and their use in developing immunotherapies
Wısnıewskı, T., & Sigurdsson, E. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.05.004 · Cited by 84
Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice
Hyde, L. A., Kazdoba, T. M., Grilli, M., Lozza, G., Brussa, R., Zhang, Q., Wong, G. T., McCool, M. F., Zhang, L., Parker, E. M., et al. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.12.017 · Cited by 83
Murphy, G. M., Zhao, F., Yang, L., & Cordell, B. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64603-2 · Cited by 80
Processing of Amyloid Precursor Protein in Human Primary Neuron and Astrocyte Cultures
LeBlanc, A. C., Papadopoulos, M., Bélair, C., Chu, W. N., Crosato, M., Powell, J., & Goodyer, C. G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68031183.x · Cited by 80
The state versus amyloid-β: the trial of the most wanted criminal in Alzheimer disease
Rottkamp, C. A., Atwood, C., Joseph, J. A., Nunomura, A., Perry, G. L., & Smith, M. A. (2002) · Peptides · doi:10.1016/s0196-9781(02)00069-4 · Cited by 81
APP transgenic mice: their use and limitations
Balducci, C., & Forloni, G. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8141-7 · Cited by 79
ROCKENSTEIN, E., CREWS, L., & MASLIAH, E. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.013 · Cited by 65
Self-citationUtter, S., Tamboli, I. Y., Walter, J., Upadhaya, A. R., Birkenmeier, G., Pietrzik, C. U., Ghebremedhin, E., & Thal, D. R. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181836a71 · Cited by 80
Sabbagh, J. J., Kinney, J. W., & Cummings, J. L. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.02.027 · Cited by 80
The possible role of complement activation in Alzheimer disease
McGeer, P. L., & McGeer, E. G. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02422-x · Cited by 80
Ingram, D. K., & Jucker, M. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00033-0 · Cited by 80
Muscarinic m1 receptor agonists increase the secretion of the amyloid precursor protein ectodomain
Müller, D., Mendla, K. D., Farber, S. A., & Nitsch, R. M. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00038-6 · Cited by 79
Apolipoprotein E mediates sulfatide depletion in animal models of Alzheimer’s disease
Cheng, H., Zhou, Y., Holtzman, D. M., & Han, X. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.020 · Cited by 79
Giannakopoulos, P., Silhol, S., Jallageas, V., Mallet, J. J., Bons, N., Bouras, C., & Delaère, P. (1997) · Acta Neuropathologica · doi:10.1007/s004010050684 · Cited by 78
Kinetics of Cerebral Amyloid Angiopathy Progression in a Transgenic Mouse Model of Alzheimer Disease
Robbins, E. M., Betensky, R. A., Domnitz, S. B., Purcell, S. M., Garcı́a-Alloza, M., Greenberg, C., Rebeck, G. W., Hyman, B. T., Greenberg, S. M., Frosch, M. P., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3854-05.2006 · Cited by 78
Changes in the ageing brain in health and disease
Anderton, B. H. (1997) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1997.0162 · Cited by 82
Cathepsin D displays in vitro β-secretase-like specificity
Chevallier, N., Vizzavona, J., Marambaud, P., Baur, C.-P., Spillantini, M. G., Fulcrand, P., Martínez, J., Goedert, M., Vincent, J., & Checler, F. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01330-3 · Cited by 78
Soto, C. A. (1999) · Journal of Molecular Medicine · doi:10.1007/s001090050371 · Cited by 78
Schenk, D. B., Seubert, P. A., Lieberburg, I. M., & Wallace, J. (2000) · Archives of Neurology · doi:10.1001/archneur.57.7.934 · Cited by 78
Self-citationAgca, C., Fritz, J. J., Walker, L. C., Levey, A. I., Chan, A. W. S., Lah, J. J., & Ağca, Y. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-28 · Cited by 79
Rat transgenic models with a phenotype of intracellular Aβ accumulation in hippocampus and cortex
Echeverrı́a, V., Ducatenzeiler, A., Alhonen, L. I., Jänne, J., Grant, S. M., Wandosell, F. G., Muro, A. F., Baralle, F. E., Li, H., Duff, K., et al. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6301 · Cited by 82
Remembering your A, B, C's: Alzheimer's disease and ABCA1
Lewandowski, C. T., Laham, M. S., & Thatcher, G. R. J. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.01.011 · Cited by 76
Mckean, N. E., Handley, R. R., & Snell, R. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313168 · Cited by 81
Anti-dementia drugs and hippocampal-dependent memory in rodents
Yuede, C. M., Dong, H., & Csernansky, J. G. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282da278d · Cited by 76
Li, X., Bao, X., & Wang, R. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2428 · Cited by 78
Single cell gene expression profiling in Alzheimer’s disease
Ginsberg, S. D., Che, S., Counts, S., & Mufson, E. J. (2006) · NeuroRx · doi:10.1016/j.nurx.2006.05.007 · Cited by 76
Functional Phenotype in Transgenic Mice Expressing Mutant Human Presenilin-1
Barrow, P. A., Empson, R. M., Gladwell, S. J., Anderson, C. M., Killick, R., Yu, X., Jefferys, J. G. R., & Duff, K. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0276 · Cited by 79
Behavioural phenotyping of mouse mutants
van der Staay, F. J., & Steckler, T. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00278-9 · Cited by 78
Amyloid precursor protein increases cortical neuron size in transgenic mice
Oh, E. S., Savonenko, A. V., King, J. F., Fangmark Tucker, S. M., Rudow, G. L., Xu, G., Borchelt, D. R., & Troncoso, J. C. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.024 · Cited by 75
Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models
Wirths, O., & Zampar, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218144 · Cited by 75
“While an age-related reduction in the density of cholinergic nerve terminals was evident in 4-month-old homozygous PDAPP mice, no difference in the number of cholinergic basal forebrain neurons was detected in even 24-month-old animals [133].”
BackgroundPoon, C. H., Wang, Y., Fung, M., Zhang, C., & Lim, L. W. (2020) · Aging and Disease · doi:10.14336/ad.2019.1026 · Cited by 76
Neurodegenerative mechanisms in alzheimer disease
Sopher, B. L., Fukuchi, K., Kavanagh, T. J., Furlong, C. E., & Martin, G. M. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02814999 · Cited by 75
Involvement of microtubule integrity in memory impairment caused by colchicine
Nakayama, T., & Sawada, T. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00634-7 · Cited by 75
Co-injection of β-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons
Morimoto, K., Yoshimi, K., Tonohiro, T., Yamada, N., Oda, T., & Kaneko, I. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00507-1 · Cited by 75
Innate Immunity, Local Inflammation, and Degenerative Disease
McGeer, P. L., & McGeer, E. G. (2002) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2002.29.re3 · Cited by 75
Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders
Malar, D. S., Thitilertdecha, P., Ruckvongacheep, K. S., Brimson, S., Tencomnao, T., & Brimson, J. M. (2023) · CNS Drugs · doi:10.1007/s40263-023-01007-6 · Cited by 77
Passive immunotherapy rapidly increases structural plasticity in a mouse model of Alzheimer disease
Spires‐Jones, T. L., Mielke, M. L., Rozkalne, A., Meyer‐Luehmann, M., de Calignon, A., Bacskai, B. J., Schenk, D., & Hyman, B. T. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.10.011 · Cited by 78
Self-citationCoomaraswamy, J., Kilger, E., Wölfing, H., Schäfer, C., Kaeser, S. A., Wegenast‐Braun, B. M., Hefendehl, J. K., Wolburg, H., Mazzella, M. J., Ghiso, J. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001056107 · Cited by 74
Astrocytes and synaptic plasticity in health and disease
Singh, A., & Abraham, W. C. (2017) · Experimental Brain Research · doi:10.1007/s00221-017-4928-1 · Cited by 78
Dewachter, I., Dorpe, J. V., Spittaels, K., Tesseur, I. C., den Haute, C. V., Moechars, D., & LEUVEN, F. V. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00149-2 · Cited by 78
Thyroid Hormones Regulate -Amyloid Gene Splicing and Protein Secretion in Neuroblastoma Cells
Latasa, M. J., Belandia, B., & Pascual, A. (1998) · Endocrinology · doi:10.1210/endo.139.6.6033 · Cited by 74
Johnson, E. C. B., Ho, K., Yu, G.-Q., Das, M., Sanchez, P. E., Djukic, B., Lopez, I., Yu, X., Gill, M., Zhang, W., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00393-5 · Cited by 73
Self-citationReddy, P. H., & McWeeney, S. K. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.04.014 · Cited by 73
The rat as an animal model of Alzheimer's disease
Benedikz, E., Kloskowska, E., & Winblad, B. G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00781.x · Cited by 77
Andrew, R. J., Fernandez, C. G., Stanley, M., Jiang, H., Nguyen, P. A. H., Rice, R. C., Buggia-Prévot, V., Rossi, P. D., Vetrivel, K. S., Lamb, R., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708568114 · Cited by 74
β‐secretase as a target for the treatment of Alzheimer's disease
Citron, M. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10393 · Cited by 73
Chapter 26 Reduced neuronal activity and reactivation in Alzheimer's disease
Swaab, D. F., Lucassen, P. J., Salehi, A., Scherder, E., Someren, E. J. W. V., & Verwer, R. W. H. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)64027-3 · Cited by 74
Roses, A. D. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80098-5 · Cited by 75
Kato, S., Gondo, T., Hoshii, Y., Takahashi, M., Yamada, M., & Ishihara, T. (1998) · Pathology International · doi:10.1111/j.1440-1827.1998.tb03915.x · Cited by 73
Lewandowski, C. T., Maldonado Weng, J., & LaDu, M. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104811 · Cited by 72
Vasilevko, V., Passos, G. F., Quiring, D., Head, E., Kim, R. C., Fisher, M., & Cribbs, D. H. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05786.x · Cited by 74
Impaired Eyeblink Conditioning and Decreased Hippocampal Volume in PDAPP V717F Mice
Weiss, C., Venkatasubramanian, P. N., Aguado, A., Power, J., Tom, B. C., Li, L. J., Chen, K. S., Disterhoft, J. F., & Wyrwicz, A. M. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0555 · Cited by 73
Adav, S. S., & Sze, S. K. (2016) · Molecular Brain · doi:10.1186/s13041-016-0272-9 · Cited by 75
Li, Q., Maynard, C. J., Cappai, R., McLean, C., Cherny, R. A., Lynch, T., Culvenor, J. G., Trevaskis, J., Tanner, J. E., Bailey, K. A., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722479.x · Cited by 73
Delayed behavioral effects following intrahippocampal injection of aggregated Aβ(1–42)
O‘Hare, E., Weldon, D. T., Mantyh, P. W., Ghilardi, J. R., Finke, M. P., Kuskowski, M., Maggio, J. E., Shephard, R. A., & Cleary, J. P. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01002-6 · Cited by 72
Bitting, L., Naidu, A., Cordell, B., & Murphy, G. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.16084 · Cited by 74
Zhong, P., Gu, Z., Wang, X., Jiang, H., Feng, J., & Yan, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302789200 · Cited by 71
Granzotto, A., Vissel, B., & Sensi, S. L. (2024) · eLife · doi:10.7554/elife.90633 · Cited by 71
Clinical applications of intravenous immunoglobulins in neurology
Hughes, R. A., Dalakas, M. C., Cornblath, D. R., Latov, N., Weksler, M. E., & Relkin, N. R. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04025.x · Cited by 71
Siwek, M. E., Müller, R., Henseler, C., Trog, A., Lundt, A., Wormuth, C., Broich, K., Ehninger, D., Weiergräber, M., & Papazoglou, A. (2015) · Neural Plasticity · doi:10.1155/2015/781731 · Cited by 71
Jolly-Tornetta, C., Gao, Z., Lee, V. M. ‐., & Wolf, B. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.14015 · Cited by 71
Kubo, T., Kumagae, Y., Miller, C. A., & Kaneko, I. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.3.248 · Cited by 71
Ford, E., Pearlman, J., Ruan, T., Manion, J., Waller, M. A., Neely, G. G., & Caron, L. (2020) · Cells · doi:10.3390/cells9112517 · Cited by 71
Sanger Mouse Genetics Project, Ryder, E. J., Gleeson, D., Sethi, D., Vyas, S., Miklejewska, E., Dalvi, P. S., Habib, B., Cook, R., Hardy, M. P., et al. (2013) · Mammalian Genome · doi:10.1007/s00335-013-9467-x · Cited by 71
Higgins, L. S., Murphy, G. M., Forno, L. S., Catalano, R., & Cordell, B. (1996) · Europe PMC (PubMed Central) · Cited by 70
Animal models of cerebral amyloid angiopathy
Jäkel, L., Nostrand, W. E. V., Nicoll, J. A. R., Werring, D. J., & Verbeek, M. M. (2017) · Clinical Science · doi:10.1042/cs20170033 · Cited by 71
Macrophage-Mediated Degradation of β-Amyloid via an Apolipoprotein E Isoform-Dependent Mechanism
Zhao, L., Lin, S., Bales, K. R., Gelfanova, V., Koger, D., DeLong, C. A., Hale, J. E., Liu, F., Hunter, J. M., & Paul, S. M. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5302-08.2009 · Cited by 70
Molecular genetics of Alzheimer’s disease
Pástor, P., & Goate, A. (2004) · Current Psychiatry Reports · doi:10.1007/s11920-004-0052-6 · Cited by 69
Fong, L. K., Yang, M. M., dos Santos Chaves, R., Reyna, S. M., Langness, V. F., Woodruff, G., Roberts, E. A., Young, J. E., & Goldstein, L. S. B. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000441 · Cited by 72
Fukuchi, K., Ho, L., Younkin, S. G., Kunkel, D. D., Ogburn, C. E., LeBoeuf, R. C., Furlong, C. E., Deeb, S. S., Nochlin, D., Węgiel, J., et al. (1996) · Europe PMC (PubMed Central) · Cited by 69
Emerging Alzheimer’s disease therapies: inhibition of β-secretase
Citron, M. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00122-7 · Cited by 69
Metadata
- Authors
- Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., Guido, T., Hagopian, S., Johnson-Wood, K., Khan, K., Lee, M., Leibowitz, P., Lieberburg, I., Little, S., Masliah, E., McConlogue, L., Montoya-Zavala, M., Mucke, L., Paganini, L., Penniman, E., Power, M., Schenk, D., Seubert, P., Snyder, B., Soriano, F., Tan, H., Vitale, J., Wadsworth, S., Wolozin, B., & Zhao, J.
- Affiliations
- Worcester Polytechnic Institute (US)
- University of Massachusetts Chan Medical School (US)
- Eli Lilly (United States) (US)
- Boston Children's Hospital (US)
- University of California San Diego (US)
- Scripps Research Institute (US)
- ORCID
- Venue
- Nature
- Published
- 1995-02
- Volume
- 373
- Issue
- 6514
- Pages
- 523-527
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2126800086
- Cited by
- 2,516
- References
- 28
- Citations by year
- 2026: 17 · 2025: 34 · 2024: 55 · 2023: 38 · 2022: 42 · 2021: 52 · 2020: 55 · 2019: 42 · 2018: 35 · 2017: 54 · 2016: 69 · 2015: 64 · 2014: 58 · 2013: 75 · 2012: 73
- FWCI
- 101.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid precursor protein, transgenic mice, amyloid-beta, amyloid plaques, neuritic plaques, synaptic loss, astrocyte activation, microglial activation, animal models of Alzheimer's disease, thioflavin S staining
- MeSH terms
- Alzheimer Disease, Animals, Base Sequence, Brain, Humans, Immunoenzyme Techniques, Mice, Transgenic, Molecular Sequence Data, Mutation, Platelet-Derived Growth Factor, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, DNA Primers, Microscopy, Confocal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
